A population-based, case-control study of green tea consumption and leukemia risk in southwestern Taiwan
- PMID: 18752033
- PMCID: PMC3103781
- DOI: 10.1007/s10552-008-9217-7
A population-based, case-control study of green tea consumption and leukemia risk in southwestern Taiwan
Abstract
Objective: This study investigated the association between green tea consumption and leukemia.
Methods: A total of 252 cases (90.3% response) and 637 controls (53.4% response) were enrolled. Controls were matched for cases on age and gender. Information was collected on participants' living habits, including tea consumption. Green tea was used as a standard to estimate the total amount of individual catechin consumption. We stratified individual consumption of catechins into four levels. Conditional logistic regression models were fit to subjects aged 0-15 and 16-29 years to evaluate separate associations between leukemia and catechin consumption.
Results: A significant inverse association between green tea consumption and leukemia risk was found in individuals aged 16-29 years, whereas no significant association was found in the younger age groups. For the older group with higher amounts of tea consumption (>550 units of catechins), the adjusted odds ratio (OR) compared with the group without tea consumption was 0.47 [95% confidence interval (CI) = 0.23-0.97]. After we adjusted for smoking status and medical irradiation exposure, the overall OR for all participants was 0.49 (95% CI = 0.27-0.91), indicating an inverse relation between large amounts of catechins and leukemia.
Conclusion: Drinking sufficient amounts of tea, especially green tea, which contains more catechins than oolong tea and black tea, may reduce the risk of leukemia.
Figures


References
-
- Kada T, Kaneko K, Matsuzaki S, Matsuzaki T, Hara Y. Detection and chemical identification of natural bio-antimutagens. A case of the green tea factor. Mutat Res. 1985;150(1–2):127–132. doi:10.1016/0027-5107(85)90109-5. - PubMed
-
- Mukhtar H, Ahmad N. Green tea in chemoprevention of cancer. Toxicol Sci. 1999;52(2 Suppl):111–117. doi:10.1093/toxsci/52.2.111. - PubMed
-
- Spinella F, Rosano L, Di Castro V, et al. Green tea polyphenol epigallocatechin-3-gallate inhibits the endothelin axis and downstream signaling pathways in ovarian carcinoma. Mol Cancer Ther. 2006;5(6):1483–1492. doi:10.1158/1535-7163.MCT-06-0053. - PubMed
-
- Zhang Q, Tang X, Lu Q, Zhang Z, Rao J, Le AD. Green tea extract and (–)-epigallocatechin-3-gallate inhibit hypoxia- and serum-induced HIF-1alpha protein accumulation and VEGF expression in human cervical carcinoma and hepatoma cells. Mol Cancer Ther. 2006;5(5):1227–1238. doi:10.1158/1535-7163.MCT-05-0490. - PubMed
-
- Mukhtar H. Cancer chemoprevention by green tea components. Adv Exp Med Biol. 1994;354:123–134. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical